Boothbay Fund Management, LLC Macrogenics Inc Transaction History
Boothbay Fund Management, LLC
- $4.17 Billion
- Q1 2024
A detailed history of Boothbay Fund Management, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 139,400 shares of MGNX stock, worth $592,450. This represents 0.05% of its overall portfolio holdings.
Number of Shares
139,400Holding current value
$592,450% of portfolio
0.05%Shares
10 transactions
Others Institutions Holding MGNX
# of Institutions
170Shares Held
62.4MCall Options Held
819KPut Options Held
79.4K-
Bellevue Group Ag Kuesnacht, V89.97MShares$42.4 Million2.3% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.15MShares$26.1 Million1.09% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$24.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$18.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$15.6 Million0.0% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $261M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...